Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CABAZITAXEL vs CABOTEGRAVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CABAZITAXEL vs CABOTEGRAVIR: Safety Overview

Metric CABAZITAXEL CABOTEGRAVIR
Total FAERS Reports 2,553 8,304
Deaths Reported 467 144
Death Rate 18.3% 1.7%
Hospitalizations 950 428
Average Patient Age 68.7 yrs 41.7 yrs
% Female Patients 2.0% 22.1%
FDA Approval Date Dec 29, 2021 Dec 20, 2021
Manufacturer Sanofi-Aventis U.S. LLC ViiV Healthcare Company
Route N/A ORAL
Marketing Status Prescription Prescription